you are here:
Home >
Our Expertise > Industries > Healthcare and Life Sciences
Healthcare and Life Sciences
The Healthcare sector across the globe is experiencing dramatic transformation. Demographic changes and an increasingly informed consumer are driving demand for more and better quality services while constraints in both public and private sector financing mean healthcare providers are being required to deliver simultaneously superior outcomes and higher productivity. Payers in both public and private sector are exploring ways to change behaviours and reward outcomes not effort. Life Science firms are reinventing their value chains to deliver cost-effective innovation using global sourcing models and increasingly focusing on personalised medicine rather than blockbuster drugs.
Across the sector, traditional models are reaching their limits. Radical changes in approach will be needed to deliver on consumers’ and investors’ expectations. Over the next 10 years we will see complete transformations in provider care pathways, drug development and healthcare funding models, with an increased focus on globalisation of healthcare markets. Innovative approaches are being developed such as retail medicine, health tourism and telemedicine to tap into more cost effective healthcare delivery; and developing economies are rapidly expanding services and using novel approaches and technologies to leapfrog performance in mature markets.
With over 10 years of experience in the sector - covering payers, providers, medical technology and life sciences - Parthenon’s Global Healthcare Practice works with executives in both the public and private sector to deliver clinical and financial success in this challenging environment. Our approach combines rigorous data-based clinical and financial analysis with process-driven implementation, training and knowledge transfer. Our teams comprise analytical and clinical experience; and our clients receive both immediate insights and support in building their long-term capabilities.